Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • Residency, Pediatrics, 1982
    Babies & Children's Hospital
  • MD, 1979
    Columbia University College of Physicians & Surgeons
  • BS, BS, 1975
    CORNELL University-The JOHNSON School

Board Certifications

  • American Board of Pediatrics

Awards & Recognition

  • Top Doctors Washingtonian (2020, 2019)
  • Top Doctors No Va Magazine (2023, 2022, 2021)

National Provider ID: 1083795694


Fran R. Cogen, M.D., C.D.E., is the director of the Childhood and Adolescent Diabetes Program at Children’s National Hospital. Her clinical interest includes intensive insulin therapy and its effect on quality of life. She is dedicated to advocating for the needs of patients and their families in managing diabetes. Dr. Cogen was named as one of the “Best Doctors in America” in 2007. Originally from New York, she has lived in the Washington, D.C., area since 1996.

Dr. Cogen served on the American Diabetes Association National Diabetes Education Recognition committee and is the Physician Representative of the National Certification Board for Diabetes Educators. Through Dr. Cogen’s perseverance, the Washington Nationals Baseball Club chose diabetes education and care as one of its three signature causes. The commitment was solidified by a $2 million lead gift from the Nationals' Dream Foundation to secure space in Children’s National's master facility plan for the building of a 6,500 sq. ft. diabetes care complex.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • Ellen Diabetes Spectrum

Research & Publications

Monaghan M, Streisand R, Stoy J, Cogen F, et al. Transitioning from Insulin to Glyburide in Permanent Neonatal Diabetes Medical and Psychosocial Challenges in an 18YearOld MaleClinical Diabetes. 2009;27(1):25-29.

Hilliard ME, Goeke-Morey M, Cogen FR, Henderson C, Streisand R. Predictors of diabetes-related quality of life after transitioning to the insulin pump. J Pediatr Psychol. 2009;34(2):137-146.

Støy J, Greeley SA, Paz VP, et al. Diagnosis and Treatment of Neonatal Diabetes a United States Experience. Pediatr Diabetes. 2008;9(5):450-459.

Cogen F, Johnson P, Pastor B, Kaplowitz. Effects of a Diabetes Clinical Pathway on Inpatient Care Quality and Efficiency in an Urban Childrens Hospital. J Clin Outcomes Manage. 2008;15:384-392.

Cogen F, Streisand R, Sarin S. Selecting Children and Adolescents for Insulin Pump Therapy Medical and Behavioral ConsiderationsDiabetes Spectrum. 2002;15(2):72-75.

4.9 / 5 4.9 out of 5 stars (based on 42 Patient/Family Ratings)

About Our Patient Satisfaction Scores

The main Patient Rating score is an average of all responses to care provider-related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

The ratings below are the average of specific questions about interactions with the care provider.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

  • 4.9 / 5

    Care Provider explanations of prob/condition

  • 5.0 / 5

    Likelihood of recommending Care Provider